Back to
FARALLON CAPITAL MANAGEMENT, L.L.C.
XGNShowing 0 of 3 quarters
Position history for
FARALLON CAPITAL MANAGEMENT, L.L.C.'s holdings in EXAGEN INC
No. Farallon Capital Management exited its XGN (Exagen) position in Q1 2020. Its Q4 2019 13F listed 577,699 shares worth $14.7M. Farallon Capital Management first reported XGN in Q3 2019 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of XGN: WASATCH ADVISORS LP, RTW INVESTMENTS, LP